Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Trial of labor after cesarean (TOLAC), formerly trial of labor versus elective repeat cesarean section for the woman with a previous cesarean section.

BIBLIOGRAPHIC SOURCE(S)

  • Wall E, Roberts R, Deutchman M, Hueston W, Atwood LA, Ireland B. Trial of labor after cesarean (TOLAC), formerly trial of labor versus elective repeat cesarean section for the woman with a previous cesarean section. Leawood (KS): American Academy of Family Physicians (AAFP); 2005 Mar. 18 p. [38 references]

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Trial of labor versus elective repeat cesarean section for the woman with a previous cesarean section. Am Fam Physician 1995 Nov 1;52(6):1763-5.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

The grades of recommendations (A, B, and C) are defined at the end of the "Major Recommendations" field.

Recommendation 1: Women with one previous cesarean delivery with a low transverse incision are candidates for and should be offered a trial of labor (TOL). (Level A)

Recommendation 2: Patients desiring trial of labor after previous cesarean (TOLAC) should be counseled that their chance for a successful vaginal birth after cesarean (VBAC) is influenced by the following: (Level B)

Positive Factors (increased likelihood of successful VBAC)

  • Maternal age <40 years
  • Prior vaginal delivery (particularly prior successful VBAC)
  • Favorable cervical factors
  • Presence of spontaneous labor
  • Nonrecurrent indication that was present for prior cesarean delivery

Negative Factors (decreased likelihood of successful VBAC)

  • Increased number of prior cesarean deliveries
  • Gestational age >40 weeks
  • Birth weight >4,000 g
  • Induction or augmentation of labor

Recommendation 3: Prostaglandins should not be used for cervical ripening or induction as their use is associated with higher rates of uterine rupture and decreased rates of successful vaginal delivery. (Level B)

Recommendation 4: TOLAC should not be restricted only to facilities with available surgical teams present throughout labor since there is no evidence that these additional resources result in improved outcomes. (Level C)

At the same time, it is clinically appropriate that a management plan for uterine rupture and other potential emergencies requiring rapid cesarean section should be documented for each woman undergoing TOLAC. (Level C)

Recommendation 5: Maternity care professionals need to explore all the issues that may affect a woman's decision including issues such as recovery time and safety. (Level C). No evidence-based recommendation can be made regarding the best way to present the risks and benefits of trial of labor after previous cesarean delivery (TOLAC) to patients.

Definitions:

Grade of Recommendations

  1. Recommendation based on consistent and good-quality, patient-oriented evidence*
  2. Recommendation based on inconsistent or limited-quality, patient-oriented evidence*
  3. Recommendation based on consensus, usual practice, opinion, disease-oriented evidence, or case series for studies of diagnosis, treatment, prevention, or screening*

*Patient-oriented evidence reflects outcomes that matter to patients: morbidity, mortality, symptoms, costs, and quality of life. Disease-oriented evidence reports intermediate, physiologic, or surrogate end points that may or may not reflect outcomes of importance to patients (e.g., blood pressure, blood chemistry, physiologic function, and pathologic findings).

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The policy was based primarily on a comprehensive review of published reports. The evidence base was comprised chiefly of large population-based and prospective cohort series. There were no randomized controlled trials which directly compared trial of labor (TOL) to elective repeat cesarean delivery (ERCD).

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Wall E, Roberts R, Deutchman M, Hueston W, Atwood LA, Ireland B. Trial of labor after cesarean (TOLAC), formerly trial of labor versus elective repeat cesarean section for the woman with a previous cesarean section. Leawood (KS): American Academy of Family Physicians (AAFP); 2005 Mar. 18 p. [38 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1995 Apr (revised 2005 Mar)

GUIDELINE DEVELOPER(S)

American Academy of Family Physicians - Medical Specialty Society

SOURCE(S) OF FUNDING

No external funding used.

GUIDELINE COMMITTEE

Trial of Labor After Cesarean (TOLAC) Policy Team

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Team Members: Eric Wall, MD, MPH, LifeWise Health Plan of Oregon; Richard Roberts, MD, JD, Department of Family Medicine, University of Wisconsin-Madison; Mark Deutchman, MD, Department of Family Medicine, University of Colorado Health Sciences Center; William Hueston, MD, Department of Family Medicine, Medical University of South Carolina; Lesley A. Atwood, MD, Allina Medical Clinic-Hastings; and Belinda Ireland, MD, MS, Clinical Sciences Analyst, American Academy of Family Physicians

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Trial of labor versus elective repeat cesarean section for the woman with a previous cesarean section. Am Fam Physician 1995 Nov 1;52(6):1763-5.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the American Academy of Family Physicians (AAFP) Web site.

Print copies: Available from American Academy of Family Physicians, 11400 Tomahawk Creek Parkway, Leawood, KS 66211.

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

None available

NGC STATUS

This summary was completed by ECRI on June 30, 1998. The information was verified by the guideline developer on December 1, 1998. This NGC summary was updated by ECRI on August 29, 2005. The updated information was verified by the guideline developer on September 20, 2005.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo